(Q39750053)

14 September 2017

1 reference

title

Cholecystokinin and schizophrenia (English)

1 reference

14 September 2017

0 references

1 reference

Nair NP

1

1 reference

14 September 2017

Lal S

series ordinal

2

1 reference

14 September 2017

Bloom DM

series ordinal

3

1 reference

14 September 2017

publication date

1 January 1986

1 reference

Progress in Brain Research

14 September 2017

published in

1 reference

14 September 2017

volume

65

1 reference

14 September 2017

page(s)

237-258

1 reference

Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of ceruletide on pituitary-hypothalamic peptides and on emotion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin in the central nervous system: A minireview

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Antipsychotic drugs stimulate prolactin release

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Climbing behaviour induced by apomorphine in mice: A potential model for the detection of neuroleptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The physiology of cholecystokinin in brain and gut

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoctapeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Progress report: caerulein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin octapeptide (CCK 26-33), nonsulfated octapeptide and tetrapeptide (CCK 30-33) in rat brain: Analysis by high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Modulation by cholecystokinins of3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Evidence for interactions between striatal cholecystokinin and glutamate receptors. CCK-8 in vitro produces a marked downregulation of 3H-glutamate binding sites in striatal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Regional Distribution of Cholecystokinin-Like Immunoreactivity in the Human Brain*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

In vivo biosynthesis of cholecystokinin in hog cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Naloxone-induced reversal of schizophrenic hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The Effects of Ceruletide in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Ontogeny of molecular forms of CCK-peptides in rat brain and gut

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Distinct cholecystokinin receptors in brain and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of cholecystokinin on thyrotropin releasing hormone (TRH) -induced serotonin potentiation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Immunological evidence of cholecystokinin-39 in porcine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of a cholecystokinin preparation on brain monoamines in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Interaction of cholecystokinin with vasoactive intestinal peptide in body shaking response to ice-water immersion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

A method for studying synaptosomal release of neurotransmitter candidates, as evaluated by studies on cortical cholecystokinin octapeptide release

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of domperidone on apomorphine-induced growth hormone secretion in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Drug-induced growth hormone and prolactin responses in schizophrenia research

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin-converting enzymes in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin in the rat spinal cord: distribution and lack of effect of neonatal capsaicin treatment and rhizotomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The effects of cholecystokinin on dopaminergic mechanisms in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Pathway of inactivation of cholecystokinin octapeptide (CCK-8) by synaptosomal fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin turnover in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Dopamine modulates cholecystokinin release in neostriatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Origin of the cholecystokinin-containing fibers in the rat caudatoputamen.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Inhibitory effect of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of Clozapine on Apomorphine-Induced Growth Hormone Secretion and Serum Prolactin Concentrations in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin appears to have antipsychotic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of CCK-33 on prolactin and apomorphine-induced growth hormone secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Clinical and neuroendocrine studies with cholecystokinin peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin inhibits tail pinch-induced eating in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Postnatal development of the cholecystokinin-gastrin family of peptides in the brain and gut of rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Localization of cholecystokinin-like immunoreactivity in isolated nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Effect of bombesin and ceruletide on prolactin, growth hormone, luteinizing hormone, and parathyroid hormone release in normal human males

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Immunochemical evidence of cholecystokinin tetrapeptides in hog brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin Receptors in the Brain: Characterization and Distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Biologic and radioimmunologic activity of cholecystokinin in regions of mammalian brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Evidence for periaqueductal cholecystokinin-substance P neurons projecting to the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Influence of peptides on (3)H-dopamine release from superfused rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Long-Term Amphetamine Treatment Decreases Brain Serotonin Metabolism: Implications for Theories of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinins in the central nervous system and neurohypophysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Ceruletide resembles antipsychotics in rats and schizophrenic patients. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

In vivo and in vitro effects of cholecystokinin on gonadotropin, prolactin, growth hormone and thyrotropin release in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Influence of cholecystokinin on central monoaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Changes in brain cholecystokinin octapeptide following lesions of the medial forebrain bundle

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Predictability and specificity of behavioral screening tests for nucleoleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Central effects of ceruletide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Cholecystokinin octapeptide, caerulein and caerulein analogues: Effects on thermoregulation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960654-8

7 January 2021

10.1016/S0079-6123(08)60654-8

Identifiers

DOI

0 references

1 reference